Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-30

FDA Approved: ATOMOXETINE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's original application for atomoxetine (generic). Atomoxetine is used to treat attention deficit hyperactivity disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

ORIG AP for ATOMOXETINE (ATOMOXETINE)